G40.83 Dravet syndrome

Name of the Condition

• Dravet syndrome
• ICD-10 Code: G40.83

Summary

Dravet syndrome is a severe, early-onset epilepsy syndrome characterized by frequent, prolonged seizures that are often resistant to treatment. It typically begins in the first year of life and is associated with developmental delays, cognitive impairment, and other neurological challenges. The condition is rare and requires specialized management due to its complexity.

Causes

Dravet syndrome is primarily caused by genetic mutations, most commonly in the SCN1A gene, which affects sodium channel function in the brain. These mutations disrupt neuronal excitability, leading to seizure activity. In some cases, the genetic cause may be unknown or involve other genes.

Risk Factors

• Family history of epilepsy or genetic predispositions
• Presence of SCN1A gene mutations or other related genetic abnormalities
• Early childhood onset of seizures (typically before 12 months of age)
• Developmental delays or neurological abnormalities

Symptoms

• Frequent, prolonged seizures (e.g., hemiclonic, generalized tonic-clonic)
• Seizures triggered by fever or temperature changes
• Developmental delays or regression in motor and cognitive skills
• Ataxia (poor coordination) and movement disorders
• Behavioral issues, such as hyperactivity or autism spectrum traits

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and diagnostic testing. An electroencephalogram (EEG) may show abnormal brain activity, while genetic testing (e.g., SCN1A gene analysis) confirms the diagnosis. MRI or CT scans may be used to rule out structural brain abnormalities.

Treatment Options

Treatment focuses on seizure control and managing associated symptoms. Antiseizure medications (e.g., clobazam, stiripentol) are commonly used, though some may worsen seizures. Other options include dietary therapies (e.g., ketogenic diet) and, in severe cases, surgery. Supportive care for developmental and behavioral challenges is also essential.

Prognosis and Follow-Up

Dravet syndrome has a poor prognosis due to treatment-resistant seizures and progressive neurological decline. Lifelong management is required, with regular follow-up to monitor seizure frequency, developmental progress, and medication side effects. Early intervention and multidisciplinary care can improve quality of life.

Complications

• Developmental delays or intellectual disability
• Movement disorders (e.g., ataxia, dystonia)
• Behavioral issues (e.g., autism spectrum disorder, ADHD)
• Increased risk of sudden unexpected death in epilepsy (SUDEP)
• Respiratory complications during prolonged seizures

Lifestyle & Prevention

• Avoid triggers like fever, illness, or overheating
• Maintain consistent sleep schedules
• Use fever-reducing medications promptly during illness
• Engage in early intervention therapies (e.g., physical, occupational, speech)
• Ensure regular medical follow-up and medication adherence

When to Seek Professional Help

Seek immediate medical attention for seizures lasting longer than 5 minutes, clusters of seizures, or seizures accompanied by fever, difficulty breathing, or loss of consciousness. Contact a healthcare provider for any new or worsening symptoms, developmental concerns, or medication side effects.

Tips for Medical Coders

Document the specific seizure types, onset age, genetic testing results (if available), and associated neurological or developmental features. Ensure clear differentiation from other epilepsy syndromes. Include details on treatment resistance and any comorbidities to support accurate coding.